Navigation Links
Pioneering Safe Medication Return Initiative Reviewed During Pharmaceutical Disposal Summit
Date:6/5/2008

Capital Returns, Inc., a GENCO Supply Chain Solutions' company, to present details of the nation's first-of-its-kind safe medicine disposal pilot during U.S. Environmental Protection Agency's (Region III) Pharmaceutical

Disposal Summit in Philadelphia.

PHILADELPHIA, June 5 /PRNewswire/ -- Capital Returns, Inc. (CRI), the pharmaceutical industry's leading processor of pharmaceutical returns, today announced that attendees at the Philadelphia area regional Pharmaceutical Disposal Summit will get a first look at a consumer medication return pilot program launched last month in a two-county area in Wisconsin. Sponsored by excelleRx and U.S. EPA Region III, the summit will include environmental and pharmaceutical executives who were invited to meet today in Philadelphia to discuss the critical issues surrounding pharmaceuticals in the environment.

CRI is set to brief attendees on "Get The Meds Out," the pioneering joint effort between the University of Wisconsin, the Wisconsin Department of Natural Resources and CRI.

The pilot program involves more than 500,000 potential participants in a two-county area. Consumers in Waukesha and Winnebago counties can call a special 800 number to receive a pre-paid shipping label. CRI will handle the calls, explain the process, provide a return authorization and send out a pre-paid label for the expired or unused medications, excluding controlled substances. Once consumers receive their pre-paid labels, they package their medicines for shipment back to CRI. Packages received by CRI are processed, separated and then disposed of through incineration. The entire process is free to consumers.

A research report published by the U.S. Geological Survey, determined that pharmaceuticals have been detected in multiple waterways throughout the U.S.

As the U.S. Drug Enforcement Agency begins its attempt to modify regulations that would potentially clear the way for more national and statewide medicine take-back programs, the significance of this first-of-its-kind pilot is already being established.

"We are honored to be invited to present our solution to pharmaceutical leaders here in Philadelphia," says Mary Hendrickson, director of Quality and Regulatory Affairs for CRI. "The Get The Meds Out program is creating national attention that will only help advance consumer understanding of the issue and ease the creation of a national medication return program in the future."

About Capital Returns, Inc.

CRI is the leader in pharmaceutical trade, sample and clinical trial returns and product recalls. CRI leverages its market position to transform pharmaceutical business activities into data-rich, systematic processes that provide critical business information and value to manufacturers, pharmacies and wholesalers. Through a state-of-the-art processing facility, CRI provides comprehensive pharmaceutical returns management services to over 40 pharmaceutical manufacturers, the biggest U.S. chain pharmacies, leading wholesalers and mail order pharmacies and specialty and infusion pharmacies. For more information, visit http://www.capitalreturns.com.


'/>"/>
SOURCE GENCO
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PSI Brings its Pioneering Efforts to a Close
2. American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher
3. Boston IVF is First in Northeast to Offer Pioneering Test of Womens Biological Clock
4. Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Womens Biological Clock
5. WRAIR investigators pioneering work on an exciting new class of antimalarial compounds
6. Acclaimed A LION IN THE HOUSE Team Honored in Washington for Pioneering Work on Pediatric Cancer
7. Pioneering Heart Surgeon, Robert E. Michler, M.D., Appointed Chair of Surgery and Surgeon-in-Chief at Einstein and at Montefiore Medical Center
8. Heart stem cell scientist to honor pioneering woman scientist in keynote speech
9. Kavli Prize awarded to Pasko Rakic, pioneering Yale neuroscientist
10. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
11. Manic phase of bipolar disorder benefits from breast cancer medication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss ... WE TV’s “Mama June: From Not to Hot,” which will begin airing on February ... Shannon, known to millions from the 2012 reality television series, “Here Comes Honey Boo ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Dr. David ... in Henderson, NV 89052. Dr. Mahon was named a 2017 Top Patient Rated ... is an online directory that recognizes local physicians and dentists who have earned ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for ... Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory ... disorder (ASD) to see films in an environment that accommodates their unique needs. ...
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for ... expert sit stand solutions representative to the Minneapolis Home and Garden Show which is ... event that is garnering national attention is the Minneapolis Convention Center. , From ...
(Date:2/22/2017)... ... February 22, 2017 , ... Gevir, a New Zealand-based company ... announced its products are coming soon to Amazon.com, the world’s largest online retailer. ... a means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, which she’d ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
(Date:2/23/2017)... , February 23, 2017 ... Market by Product (X-ray Imaging Digital, Analog), MRI (Closed, ... (OB/GYN, MSK, Cardiology, Oncology), End User (Hospitals, Imaging Centers) ... report studies the global market over the forecast period ... reach ~USD 36.43 Billion by 2021, at a CAGR ...
Breaking Medicine Technology: